Mankind Pharma Q1 FY27 profit rises 29.6% to ₹568 crore as revenue grows 12.9%
Mankind Pharma reported Q1 FY27 revenue from operations of ₹4,030.6 crore and a 14.1% net margin, helped by a 35.6% fall in finance costs. Its board also approved a corporate guarantee of up to ₹150 crore for Bharat Serums and Vaccines and a ₹49 crore sale of its Broadway Hospitality stake.
Mankind Pharma’s Q1 FY27 net profit rose 29.6% to ₹568.06 crore as revenue grew 12.9% and finance costs fell. The board approved a ₹150 crore guarantee for Bharat Serums and Vaccines and agreed to sell its Broadway Hospitality stake for ₹49 crore.
Why this matters
The earnings follow Mankind Pharma’s Q1 FY27 modern trade and e-commerce mix reaching 15%, while its planned condom price hike signals pressure from petroleum-linked inputs amid the West Asia conflict.
Retail-company signals are accelerating, up 253340% QoQ.